TP53 and prostate carcinoma: Additionally, the enriched pathways included the “p53 signaling pathway,” “toll-like receptor signaling pathway,” “MAPK signaling pathway,” “apoptosis,” “VEGF signaling pathway,” and a variety of tumor-related pathways, such as “prostate cancer,” “bladder cancer,” “pancreatic cancer,” and “small cell lung cancer.” This result comprehensively shows that AM has good antitumor activity and validates the reliability of the prediction target.